Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis

Peter Takacs,1 Urja Lathia,2 Janey Shin,2 Francois Nantel2 1Jan-Cil Hungary, Budapest, Hungary; 2Medical Affairs, Janssen Inc., Toronto, ON, Canada Background: The aim of the study was to compare drug survival rate of subcutaneous tumor necrosis factor alpha inhibitors in rheumatoid arthritis, ank...

Full description

Bibliographic Details
Main Authors: Takacs P, Lathia U, Shin J, Nantel F
Format: Article
Language:English
Published: Dove Medical Press 2019-01-01
Series:Patient Preference and Adherence
Subjects:
Online Access:https://www.dovepress.com/persistence-to-subcutaneous-biological-agents-in-hungarian-patients-tr-peer-reviewed-article-PPA